Bedoradrine: Phase Ib start

By year end, MediciNova will begin a placebo-controlled Phase Ib trial to evaluate multiple doses of 1,200 µg IV MN-221 in patients with moderate to severe COPD. MediciNova has ex-Japanese rights to t...